Skip to content

Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior Resection

Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior Resection

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00468416
Enrollment
60
Registered
2007-05-02
Start date
2007-02-28
Completion date
2008-02-29
Last updated
2007-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

The purpose of this study is to evaluate the safety and effectiveness of the NiTi CAR device in the creation of colorectal anastomosis

Interventions

DEVICECompression Anastomosis Ring (CAR)

Sponsors

Rabin Medical Center
CollaboratorOTHER
Kaplan Medical Center
CollaboratorOTHER
Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient age over 18 years * Patient scheduled for colorectal cancer surgery * Patient is able to comprehend and sign the Informed Consent Form

Exclusion criteria

* Patient has known allergy to nickel * Patient with bowel obstruction, bowel strangulation, peritonitis, bowel perforation, local or systemic infection * Patients who are participating in another trial * Patient on regular steroid medication * Patients who are undergoing a stoma * Patients with contraindications to general anesthesia * Patient with preexisting sphincter problems or evidence of extensive local disease in the pelvis * Patients after radiation * Patients who refuse consent

Design outcomes

Primary

MeasureTime frame
Functioning anastomosis and no occurrence of adverse events related to device useDuring hospitalization and one month post procedure

Countries

Israel

Contacts

Primary ContactHagit Tulchinsky, M.D.
hagitt@tasmc.health.gov.il+972-3-6973315

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026